30 August 2018
Visiongain has launched a new pharma report Advanced Wound Care Market Forecast 2018-2028 : Revenue Prospects by Products for Active Wound Care Dressings (Antimicrobial, Foam, Hydrocolloid, Film, Alginate, Hydrogel, Other), Wound Care Devices (NPWT, Ultrasound, Other) and Wound Care Biologics (Skin Replacement, Collagen-Based, Cell-Based, Other), Applications, End-Users and National Market.
Being the largest and fastest growing segment of the wound care market, the advanced wound care market will witness healthy growth during the forecast period. The increasing prevalence of chronic wounds such as venous ulcers, diabetic ulcers and pressure sores is creating demand for more innovative products. It is estimated that around 89 million wounds occur every year; of these around 30 million are chronic wounds and 15 million are burns. Chronic wound incidences will be boosted by the increase in the global over-65 population and rising diabetes incidence both in emerging and mature economies.
The lead analyst of the report commented "The advanced wound care market is expected to experience considerable growth over the forecast period. The main drivers for the growth include an increasingly ageing population, rising prevalence of diabetes and obesity, and growing patient awareness of available products.
In the case of patients suffering from chronic wounds, wound care has become a necessity in order to reduce the risk of morbidity. The number of patients suffering from all forms of chronic wounds is increasing worldwide at around 8% per year; this increasing incidence provides an avenue for substantial growth in the advanced wound care market over the coming years."
Leading companies featured in the report include Acelity, Coloplast, ConvaTec, Mölnlycke, Organogenesis, Smith & Nephew. Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100 About Visiongain Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The biologics market is estimated at US$447 billion in 2023 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.
20 November 2023
The global mRNA Vaccines market is estimated at US$11,773.3 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.
08 November 2023
The global Stem Cell Technologies and Applications market is estimated at US$10,059.6 million in 2023 and is projected to grow at a CAGR of 8.7% during the forecast period 2023-2033.
06 November 2023
The global Neurology Clinical Trials market is valued at US$9,609.2 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033.